A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ALS-008176 in Healthy Japanese Adult Participants

Clinical trial NCT02478333 · COMPLETED

Trial details

NCT number: NCT02478333
Sponsor: Janssen Pharmaceutical K.K.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infections

Start date: 2015-05-01
Primary completion: 2015-07-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.